Quote:
Originally Posted by opendoor
That one will be good if it pans out, but it hasn't even done Phase 1 trials yet. And I'm not really sure what technical benefit it really offers over other ones, as it's essentially just throwing a bunch of different spike proteins into one vaccine.
|
I think you answered the question; strong protection across several coronavirus variants, not just a single one based on whatever strain the current vaccine was designed for.